definiens: shall mean all information or materials possessed or developed by either Party or theirrespective Affiliates, whether before or after the Execution Date, related to such Party ’s or its Affiliates ’ business, including the manufacture, Development and/or Commercialization of any pharmaceutical products hereunder, including any information or materials on substances, formulations, techniques, technology, equipment, data, reports, Know - How, sources for and methods of supply, patent position and business plans ; provided, however, thatConfidential Information shall not include information or material that ( i ) is already in the receiving Party ’s or itsAffiliate ’s lawful possession at the time of disclosure by the disclosing Party, as established by relevant documentaryevidence ; ( ii ) is already in the public domain as of the Execution Date by reason of prior publication or otherwise;(iii ) is received by a receiving Party or an Affiliate thereof on an unrestricted basis from a Third Party other than thedisclosing Party, where such Third Party is authorized to disclose such information ; ( iv ) becomes part of the publicdomain after the Execution Date through no act, omission or fault of the receiving Party ; or ( v ) is similar in nature tothe purported confidential information but which the receiving Party can demonstrate has been independently created, as established by relevant documentary evidence